Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy.

Introduction: The incidence of advanced renal cell carcinoma (RCC) is increasing. Over the last ten years targeted therapies have led to improved efficacy outcomes for renal carcinoma, including lo...